Usp5 Links Suppression of P53 and FAS Levels in Melanoma to the BRAF Pathway

Oncotarget - United States
doi 10.18632/oncotarget.2140
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

P53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

Cell
BiochemistryGeneticsMolecular Biology
2019English

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

P53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer

Cell
BiochemistryGeneticsMolecular Biology
2016English

Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

PLoS ONE
Multidisciplinary
2015English

Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma

Cancer Discovery
Oncology
2019English

A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-mutant Melanoma

Cancer Research
Cancer ResearchOncology
2020English

Suppression of P53-Dependent Senescence by the JNK Signal Transduction Pathway

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Disruption of the MDM2–p53 Interaction Strongly Potentiates P53-Dependent Apoptosis in Cisplatin-Resistant Human Testicular Carcinoma Cells via the Fas/FasL Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy